The Connectivity Map: a new tool for biomedical research
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The ultimate objective of biomedical research is to connect human diseases with the genes that underlie them and drugs that treat them. But this remains a daunting task, and even the most inspired researchers still have to resort to laborious screens of genetic or chemical libraries. What if at least some parts of this screening process could be systematized and centralized? And hits found and hypotheses generated with something resembling an internet search engine? These are the questions the Connectivity Map project set out to answer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, they do not support complex molecular readouts such as transcriptome profiling, which is one of the most comprehensive and informative measures of cellular response 5 .”
From Pooled CRISPR screening with single-cell transcriptome readout. (2017) · cites this paper as [5]
In the citing paper
“This tool allowed researchers to investigate genome-wide effects of GHK and establish that GHK-Cu is able to up- and down-regulate a significant number of human genes.”
From Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (2018) · cites this paper as [3]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationDruker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243 · cited 1×
“) to rationality (chronic myeloid leukaemia–BCR-ABL–imatini”
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Cited by
Items 501–600 of 984
Liu, X., Xu, H., Chen, M., Tan, X., Chen, X., Yang, Y., Lin, M., Liu, G., Liang, X., Qian, Y., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.2818 · Cited by 12
Wang, M., Shi, Y., Yao, L., Li, Q., Wang, Y., & Fu, D. (2020) · Medical Science Monitor · doi:10.12659/msm.924092 · Cited by 15
“The DGIdb (drug-gene interaction) and CMAP (connectivity map) databases provide the potential to discover the relationship among drugs, genes, and diseases [21,22], and there have been many studies on therapeutic targets and drugs for diseases screened from these databases, including ischemic stroke, obesity, osteonec…”
BackgroundHongo, H., Kosaka, T., Suzuki, Y., Mikami, S., Fukada, J., & Oya, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-01697-2 · Cited by 12
Increased ATP2A1 Predicts Poor Prognosis in Patients With Colorectal Carcinoma
Zhang, G., Shang, H., Liu, B., Wu, G., Wu, D., Wang, L., Li, S., Wang, Z., Wang, S., & Yuan, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.661348 · Cited by 15
“These algorithms can find the functional relationship between drugs, genes, and diseases (Lamb et al., 2006; Lamb, 2007).”
BackgroundRouillard, A. D., Wang, Z., & Ma’ayan, A. (2015) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2015.08.005 · Cited by 12
“5 patterns across gene expression signatures of DE genes [18].”
BackgroundA computational strategy for finding novel targets and therapeutic compounds for opioid dependence
Wu, X., Xie, S., Wang, L., Fan, P., Ge, S., Xie, X., & Wu, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207027 · Cited by 14
“This software provided a modified form of the rank-based enrichment statistics to compare the two sets of the DEGs [64, 65].”
MethodDalpé, G., & Joly, Y. (2014) · Drug Development Research · doi:10.1002/ddr.21211 · Cited by 14
“Datasets of the Connectivity Map [Lamb, 2007; Broad Institute, 2014], a repository of 1,309 small biomolecules that can be screened against genome-wide disease signatures, have led to the identification of a novel autophagic activity for the Rho-kinase inhibitor, fasudil [Nagumo et al., 2000;…”
BackgroundHuré, J.-B., Foucault, L., Ghayad, L. M., Marie, C., Vachoud, N., Baudouin, L., Azmani, R., Ivljanin, N., Arevalo-Nuevo, A., Pigache, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54003-9 · Cited by 12
“27].”
Multi-omics analysis to explore the molecular mechanisms related to keloid
Xu, H., Li, K., Liang, X., Wang, Z., & Yang, B. (2025) · Burns · doi:10.1016/j.burns.2025.107396 · Cited by 12
Multimodal diagnostic models and subtype analysis for neoadjuvant therapy in breast cancer
Ye, Z., Yuan, J., Hong, D., Xu, P., & Liu, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1559200 · Cited by 20
“We searched the Connectivity Map (CMap) database (86) (https://clue.io/cmap) to identify potential chemicals that could induce opposite transcriptomic alterations to those observed in the nonresponse group compared to the response group.”
Ushijima, M., Mashima, T., Tomida, A., Dan, S., Saito, S., Furuno, A., Tsukahara, S., Seimiya, H., Yamori, T., & Matsuura, M. (2012) · Cancer Science · doi:10.1111/cas.12071 · Cited by 11
Liu, X., Zeng, P., Cui, Q., & Zhou, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179037 · Cited by 11
Rankin, R., Lundy, F. T., Schock, B. C., Zhang, S. ‐., Al‐Natour, B., About, I., Irwin, C., Linden, G. J., & El‐Karim, I. A. (2020) · International Endodontic Journal · doi:10.1111/iej.13281 · Cited by 11
Zheng, Z., Xie, J., Xiong, L., Gao, M., Li, Q., Dai, C., Liang, Z., Wang, Y., Xue, J., Wang, Q., et al. (2020) · Medical Oncology · doi:10.1007/s12032-020-01425-2 · Cited by 11
“org/CMap/) was used for screening of related active small molecules [15].”
BackgroundPrediction of Cancer Treatment Using Advancements in Machine Learning
Singh, A. K., Ling, J., & Malviya, R. (2022) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892818666221018091415 · Cited by 13
Liu, H., Yu, B., Deng, Z., Zhao, H., Zeng, A., Li, R., & Fu, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1075395 · Cited by 11
Zhang, J., Cao, Y., Ren, R., Sui, W., Zhang, Y., Zhang, M., & Zhang, C. (2024) · Advanced Science · doi:10.1002/advs.202306232 · Cited by 18
GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas
Hua, H., Liang, L., Jiang, S., Liu, Y., Huang, J., Sun, X., Li, Y., Jiang, Y., & Li, C. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06586-w · Cited by 11
“The Connectivity Map (CMap) is a database that correlates perturbagens, gene expression, and disease using differentially expressed gene data following the treatment of human cells with different perturbagens [28, 29].”
InfluentialDrug Targets, Target Identification, Validation, and Screening
den Broeck, W. M. M. V. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417205-0.00003-1 · Cited by 12
Deng, T., Gong, Y., Liao, X., Wang, X., Zhou, X., Zhu, G., & Mo, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650828 · Cited by 11
“org/ cmap/) online tool to identify potential drugs for LGG patients with a high-risk phenotype (16, 17).”
MethodCellular, molecular, and therapeutic characterization of pilocarpine-induced temporal lobe epilepsy
Henkel, N., Smail, M. A., Wu, X., Enright, H. A., Fischer, N. O., Eby, H., Carney, P. R., McCullumsmith, R. E., & Shukla, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-98534-3 · Cited by 11
“451 Next, drug-specific gene markers (associated with the connectivity map database (Lamb, 2007)) that 452 were attributed to up- and downregulated effects were downloaded from the Enricher library of gene 453 sets (Kuleshov et al.”
MethodInfluentialDai, D., Guo, Y., Shui, Y., Li, J., Jiang, B., & Wei, Q. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.775562 · Cited by 11
“CMap analysis is a method that uses a reference drug-specific gene expression profile dataset and compares it with a diseasespecific gene expression profile to identify potential drugs for a specific phenotype (Lamb, 2007; Musa et al., 2018).”
MethodLiu, Y., Sun, J., Han, D., Cui, S., & Yan, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.858633 · Cited by 12
“Identification of Candidate Small Molecules CMap is a program for predicting potential drugs that may induce biological states encoded by specific gene expression signatures (Lamb, 2007).”
BackgroundBenchmark of embedding-based methods for accurate and transferable prediction of drug response
Jia, P., Hu, R., & Zhao, Z. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad098 · Cited by 12
A drug repurposing method based on inhibition effect on gene regulatory network
Li, X., Liao, M., Wang, B., Zan, X., Huo, Y., Liu, Y., Bao, Z., Xu, P., & Liu, W. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.09.007 · Cited by 11
“[15,16] developed Connectivity Map (CMAP) database, which compared drug and disease expression profiles to discover potential drug candidates.”
An integrated network platform for contextual prioritization of drugs and pathways
Segura‐Cabrera, A., Singh, N., & Komurov, K. (2015) · Molecular BioSystems · doi:10.1039/c5mb00444f · Cited by 11
“[1 , 2] Comparative analyses of these drug signatures allow for the identification of novel drug-drug similarities, and hence, novel drug-target pairings; a paradigm that has been extensively exploited.”
BackgroundWathieu, H., Issa, N. T., Fernandez, A. I., Mohandoss, M., Tiek, D. M., Franke, J. L., Byers, S. W., Riggins, R. B., & Dakshanamurthy, S. (2017) · Oncotarget · doi:10.18632/oncotarget.21669 · Cited by 12
Hoque, M., Abbassi, R. H., Froio, D., Man, J., Johns, T. G., Stringer, B. W., Day, B. W., Pajic, M., Kassiou, M., & Munoz, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.023 · Cited by 12
Liao, S.-C., Hsu, H.-W., Chuang, K.-L., Huang, Z.-Y., Lin, K., Hsu, W., Chang, K.-H., Huang, C. F., & Su, C. (2019) · Nutrients · doi:10.3390/nu11061397 · Cited by 11
“The C-Map (invented by the Broad Institute of the Massachusetts Institute of Technology and Harvard University) contains gene expression profiles with four specific human cancer cell lines (breast cancer MCF7, prostate cancer PC3, leukemia HL60, and melanoma SKMEL5) treated with small bioactive molecules, including ap…”
BackgroundIsozaki, Y., Hoshino, I., Akutsu, Y., Hanari, N., Mori, M., Nishimori, T., Murakami, K., Akanuma, N., Toyozumi, T., Takahashi, M., et al. (2014) · Oncology · doi:10.1159/000365592 · Cited by 13
Zheng, X., Wang, Y., & Qiu, X. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176840 · Cited by 10
Advances in high-throughput drug screening based on pharmacotranscriptomics
Qiao, L., Huo, X., Huang, W., Wang, Z., Ren, Y., Liu, Y., Li, Q., & Zhang, Y. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.006 · Cited by 11
“CMap indicated the feasibility of PTDS [22].”
Liu, J., Li, R., Liao, X., Hu, B.-L., & Yu, J. (2019) · Journal of Cancer · doi:10.7150/jca.31675 · Cited by 16
“org/ cmap/; accessed November 1, 2018) is a biological application database of small-molecule drugs, gene expression profiles, and diseases, which is based on the differential gene expression of human cells treated with small-molecule drugs [19, 20].”
BackgroundHsieh, Y., Du, J., & Yang, P. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13536 · Cited by 18
“The CMap database consists of gene expression signatures from small-molecule-treated human cancer cell lines, which can be used to compare queried and existing gene signatures, and then the connections among small molecules sharing similar MOAs can be found [10,27].”
BackgroundLiang, P., Zhu, M., Sun, X., Wang, L. P., Li, B., Ming, S., Younis, M., Yang, J., Wu, Y., & Huang, X. X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112916 · Cited by 12
Edberg, A., Soeria‐Atmadja, D., Laurila, J. B., Johansson, F., Gustafsson, M. G., & Hammerling, U. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200429f · Cited by 10
Harnessing Systems Biology Approaches to Engineer Functional Microvascular Networks
Sefcik, L. S., Wilson, J. L., Papin, J. A., & Botchwey, E. A. (2010) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2009.0611 · Cited by 10
“57 Ultimately, the goal of the Connectivity Map project is to connect human diseases with the genes that underlie them and the drugs that can treat them.”
Early Repositioning Through Compound Set Enrichment Analysis: A Knowledge-Recycling Strategy
Temesi, G., Bolgár, B., Arany, Á., Szalai, C., Antal, P., & Mátyus, P. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.4 · Cited by 12
The pharmacogenetic background of hepatitis C treatment
Schlecker, C., Ultsch, A., Geißlinger, G., & Lötsch, J. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.02.001 · Cited by 10
Masamoto, Y., & Kurokawa, M. (2018) · Stem Cell Investigation · doi:10.21037/sci.2018.03.05 · Cited by 10
“By using Connectivity Map (CMAP) database, the authors tried to find compounds that can induce gene expression changes recapitulating those caused by Tcf1/Lef1 loss in LSCs (25).”
MethodWen, Q., Liu, R., & Zhang, P. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01617-4 · Cited by 10
“atasets. During this process, we will include as many laboratory tests as we can in our experiment to completely represent the state of human biological system. The idea of CMap raised by Lamb et al. [7,8] which uses gene expression values to bridge drugs and diseases, directly inspires us to formulate and leverage al…”
BackgroundComputational tools for analyzing single-cell data in pluripotent cell differentiation studies
Ding, J., Alavi, A., Ebrahimkhani, M. R., & Bar‐Joseph, Z. (2021) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100087 · Cited by 10
“The methods work by looking for drugs that lead to expression patterns that ‘‘reverse’’ differences observed between healthy and diseased tissue for an individual (Lamb, 2007).”
BackgroundMachine Learning and Deep Learning Strategies in Drug Repositioning
Wang, F., Ding, Y., Lei, X., Liao, B., & Wu, F. (2021) · Current Bioinformatics · doi:10.2174/1574893616666211119093100 · Cited by 10
Jin, L., Mi, T., Wu, X., Wang, Z., Zhang, Z., Liu, J., Wang, Z., Wang, J., Li, M., Ren, C., et al. (2023) · Cancers · doi:10.3390/cancers15072023 · Cited by 12
“Here, we used the prognosis-related genes of neuroblastoma to predict drugs based on the Connectivity Map database [1,10,11], and successfully identified the potential therapeutic drug BI-D1870 for neuroblastoma.”
MethodPan, J., Liu, S., Farkas, M. H., Consugar, M. B., Zack, D. J., Kozak, I., Arévalo, J. F., Pierce, E. A., Qian, J. X., & Kahtani, E. A. (2016) · Europe PMC (PubMed Central) · Cited by 11
Deubiquitinases as Anticancer Targets of Gold Complexes
Zou, T.-T., Zhang, J.-J., Cao, B., Tong, K.-C., Lok, C.-N., & Che, C. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600044 · Cited by 9
Systems-Mapping of Herbal Effects on Complex Diseases Using the Network-Perturbation Signatures
Chen, X., Zheng, C., Wang, C., Guo, Z., Gao, S., Ning, Z., Huang, C., Lu, C. C., Fu, Y., Guan, D., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01174 · Cited by 11
“For example, the “Connectivity Map” (Lamb et al., 2006; Lamb, 2007), one of the most promising approaches, is a method based on “gene signatures.””
MethodA new severe congenital neutropenia syndrome associated with autosomal recessive COPZ1 mutations
Bravo, N. B., Деордиева, Е. А., Doll, L., ElGamacy, M., Dannenmann, B., Azevedo, J., Iannuzzo, A., Delafontaine, S., Lehners, M., Kolodziej, M., et al. (2024) · Blood · doi:10.1182/blood.2023022576 · Cited by 9
Galahad: a web server for drug effect analysis from gene expression
Laenen, G., Ardeshirdavani, A., Moreau, Y., & Thorrez, L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv436 · Cited by 13
The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
Puhl, A. C., Lane, T. R., Urbina, F., & Ekins, S. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.837587 · Cited by 9
“This is analogous to the connectivity map (CMap), which brings together data on genes and thousands of drugs and disease states used in several repurposing projects to identify new uses for old drugs (Lamb et al., 2006; Lamb, 2007; Zimmer et al., 2010; Subramanian et al., 2017).”
MethodThe 3Rs in Experimental Liver Disease
Martínez‐López, S., Ángel‐Gomis, E., Sánchez, E., Pastor-Campos, A., Picó, J., & Gómez‐Hurtado, I. (2023) · Animals · doi:10.3390/ani13142357 · Cited by 10
“), or toxicologic information, to better predict the required endpoints [109,110].”
BackgroundGu, Q., Chen, X., Xiao, Y.-B., Chen, L., Xue-feng, W., Fang, J., Chen, B., & Hao, J. (2014) · Pediatric Cardiology · doi:10.1007/s00246-014-0868-8 · Cited by 10
“The connectivity map (CMap) [17, 18] database contains data for 7,056 gene-expression profiles involving 6,100 small molecule treatment-control pairs.”
MethodZhang, X., Yin, A., Lin, D.-J., Zhu, X., Ding, Q., Wang, C., & Chen, Y. (2012) · BioMed Research International · doi:10.1155/2012/654291 · Cited by 9
“To gain a better understanding of the anticancer and proapoptotic mechanisms of VPA exposure in a CML model, the gene expression profile of differentially expressed genes related to VPA treatment was used to compare with those of 1,309 compounds in the CMAP database [23, 24].”
MethodHamed, M., Gladbach, Y. S., Möller, S., Fischer, S., Ernst, M., Struckmann, S., Storch, A., & Fuellen, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-25754-5 · Cited by 9
Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors
Unzue, A., Jessen‐Trefzer, C., Spiliotopoulos, D., Gaudio, E., Tarantelli, C., Dong, J., Zhao, H., Pachmayr, J., Zahler, S., Bernasconi, E., et al. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00049c · Cited by 9
Atractyloside targets cancer-associated fibroblasts and inhibits the metastasis of colon cancer
Qi, L., Song, F., Han, Y., Zhang, Y., & Ding, Y.-Q. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-1531 · Cited by 9
“Connectivity Map collected the expression profiles of tumor cells treated with 1,309 small molecular compounds (19,20).”
BackgroundLesiński, W., Mnich, K., Golińska, A. K., & Rudnicki, W. R. (2021) · Biology Direct · doi:10.1186/s13062-020-00286-z · Cited by 11
Huang, T., Peng, K., Kuo, T., Lin, L.-C., Liu, B.-C., Ye, S.-P., Chu, C.-C., Hsia, S., & Chang, H. (2021) · Biomedicines · doi:10.3390/biomedicines9080882 · Cited by 9
“By reversely matching the 5-FU gene signatures to drug-induced patterns in the Connectivity Map database [20], we found that the RHO kinase inhibitor can sensitize resistant HCT116 cells to 5-FU treatment.”
BackgroundDRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer Datasets
Obermayer, A., Li, D., Hu, Q., Golden, M., Noble, J. D., Rodríguez, P. C., Robinson, T. J., Teng, M., Tan, A. C., & Shaw, T. I. (2022) · Biology · doi:10.3390/biology11020260 · Cited by 9
“A connectivity map-inspired strategy [29,30] was applied to compare the consistency between the two datasets using reciprocal enrichment.”
MethodIdentification of candidate target genes of pituitary adenomas based on the DNA microarray
Zhou, W., Ma, C., Xing, Y., & Yan, Z. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4785 · Cited by 9
Wen, Q., Dunne, P. D., O’Reilly, P. G., Li, G., Bjourson, A. J., McArt, D. G., Hamilton, P. W., & Zhang, S. (2016) · Oncotarget · doi:10.18632/oncotarget.13884 · Cited by 9
“Using a reference database, a query signature and a matching algorithm, it creates a link between genes, drugs and a biological condition [17].”
BackgroundMethodAn integrative method to predict signalling perturbations for cellular transitions
Zaffaroni, G., Okawa, S., Morales‐Ruiz, M., & del Sol, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz232 · Cited by 11
Identification of potentially anti-COVID-19 active drugs using the connectivity MAP
Bonnet, R., Mariault, L., & Peyron, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262751 · Cited by 9
“Then, with these genes, we queried the CMap database containing perturbagen-driven gene expression profiles (GEP) [13, 14] to identify molecules able to generate GEPs that negatively correlate with the provided COVID-19 gene signature.”
MethodInfluentialDas, S., Singh, S., Satpathy, S., Bhasin, M., & Kumar, A. (2022) · iScience · doi:10.1016/j.isci.2022.104862 · Cited by 9
“…for drug repurposing, comprising >7,000 genomic profiles corresponding to 1,309 small bioactive molecules and FDA-approved drugs (Lamb et al., 2006; Lamb, 2007) and identified an anti-protozoal drug for the treatment of renal (Zerbini et al., 2014), lung cancer (Jahchan et al., 2013), and…”
Ma, J., Li, Q., Ji, D., Luo, L., & Hong, L. (2021) · Bioengineered · doi:10.1080/21655979.2021.1917981 · Cited by 9
“pioneered the usage of transcriptome data by creating a repertoire of reference transcriptomes of existing drugs [35].”
BackgroundPrediction and identification of synergistic compound combinations against pancreatic cancer cells
KalantarMotamedi, Y., Choi, R. J., Koh, S.-B., Bramhall, J. L., Fan, T.-P., & Bender, A. (2021) · iScience · doi:10.1016/j.isci.2021.103080 · Cited by 8
A novel approach for predicting upstream regulators (PURE) that affect gene expression
Nguyen, T., Craig, D. B., Tran, D., Nguyen, T., & Drăghici, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-41374-0 · Cited by 8
O'Brien, J. A., & Rizzieri, D. A. (2013) · Cancer Investigation · doi:10.3109/07357907.2012.700986 · Cited by 10
“Cancer Investigation In an effort to overcome these difficulties, Lamb (33) and his group began to develop a reference databank, termed The Connectivity Map, that catalogs data detailing geneexpression in human cells in vitro as altered with a variety of chemical compounds (called “perturbagens”).”
BackgroundMethodInfluentialWhere can biology of childhood ALL be attacked by new compounds?
Bourquin, J., & Izraeli, S. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.005 · Cited by 11
Gene expression profiling analysis of keloids with and without hydrocortisone treatment
Wang, H., Quan, L., Liang, J., Shi, J., Qiu, T., Zhang, Y., Wang, Y., Hui, Q., Zhang, Y., & Tao, K. X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5263 · Cited by 8
“org/cmap) (17) was used to predict candidate small molecule drugs targeting DEGs genesets A and C.”
MethodWang, X., Peng, J., Zhou, C., Que, Q., Li, H., He, Y., & Yang, H. (2020) · Oncology Reports · doi:10.3892/or.2020.7545 · Cited by 8
“This database enables the identification of drugs that affect the same molecular pathway as identified differentially expressed genes (29-31).”
BackgroundZhang, Z., Ye, C., Liu, J., Xu, W., Wu, C., Yu, Q., Xu, X., Zeng, X., Jin, H., Wu, Y., et al. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0473 · Cited by 8
“Using the cMAP database, the expression characteristics of JAtreated cells were compared with that of cells treated with other compounds (22, 23).”
Human Protein Complex-Based Drug Signatures for Personalized Cancer Medicine
Wang, F., Ding, Y., Lei, X., Liao, B., & Wu, F. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2021.3120933 · Cited by 8
Corton, J. C., Liu, J., Kleinstreuer, N., Gwinn, M. R., & Ryan, N. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109995 · Cited by 8
Koido, M., Tani, Y., Tsukahara, S., Okamoto, Y., & Tomida, A. (2018) · Oncotarget · doi:10.18632/oncotarget.25624 · Cited by 11
“In the field of biomedical research, the connectivity map (CMap) team developed a transcriptome database, composed of five human cell lines treated with 1309 small compounds [4, 5].”
BackgroundGESgnExt: Gene Expression Signature Extraction and Meta-Analysis on Gene Expression Omnibus
Yan, S., & Wong, K. (2019) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2019.2896144 · Cited by 8
“The concept of gene expression signature was first proposed in [4] and further developed to build CMap [5].”
BackgroundHan, L., Sayyid, Z. N., & Altman, R. B. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008631 · Cited by 8
“Our approach involves curating and combining multiple publicly available resources, including Reactome [20], the Connectivity Map [39], DrugBank [19], and the Gene Expression Omnibus.”
MethodInfluentialHe, Y., Chen, Y., Tong, Y., Long, W., & Liu, Q. (2021) · PeerJ · doi:10.7717/peerj.11894 · Cited by 8
“Functional connections between drugs, genes, and diseases were then uncovered using patternmatching algorithms and features of common gene expression changes (Lamb, 2007; Lamb He et al. (2021), PeerJ, DOI 10.7717/peerj.11894 5/29 et al., 2006).”
InfluentialFang, L., Shi, L., Wang, W., Chen, Q., & Rao, X. (2021) · Medicine · doi:10.1097/md.0000000000027257 · Cited by 8
“Connectivity Map (CMap) is a tool utilized to study the relationship between smallmolecular compounds and certain genes.([11]) To upload eligible data for CMap, we converted gene symbol ID of all DEGs into probe sets.”
MethodHuang, H., Liao, X., Zhu, G., Han, C., Wang, X.-K., Yang, C., Zhou, X., Liang, T., Huang, K., & Peng, T. (2022) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s349350 · Cited by 8
“Furthermore, we also used a variety of functional enrichment analysis methods to preliminarily identify the molecular mechanisms of ACBD4 in HBV-related HCC.”
BackgroundInfluentialTargeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma
Li, Q., Demir, S., Río-Álvarez, Á. D., Maxwell, R., Wagner, A. E., Carrillo-Reixach, J., Armengol, C., Vokuhl, C., Häberle, B., von Schweinitz, D., et al. (2022) · Cancers · doi:10.3390/cancers14174196 · Cited by 10
Huang, S., Hu, P., & Lakowski, T. M. (2022) · The Pharmacogenomics Journal · doi:10.1038/s41397-022-00297-1 · Cited by 8
“In order to assist in identifying novel compounds that might modulate the FOXM1 and PPARA pathways, the Connectivity Map (CMAP) database [25] was used in this study.”
MethodOn Different Aspects of Network Analysis in Systems Biology
Chaiboonchoe, A., Jurkowski, W., Pellet, J., Glaab, E., Kolodkin, A. N., Raussel, A., Béchec, A. L., Ballereau, S. J., Meyniel‐Schicklin, L., Crespo, I., et al. (2013) · Springer eBooks · doi:10.1007/978-94-007-6803-1_6 · Cited by 8
“[50] developed by the Broad Institute aims to create a map connecting genes, diseases and drugs using a repository of gene expression profiles to represent”
BackgroundMethodPrioritizing Cancer Therapeutic Small Molecules by Integrating Multiple OMICS Datasets
Lv, S., Xu, Y., Chen, X., Li, Y., Li, R., Wang, Q., Li, X., & Su, B. (2012) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2012.0005 · Cited by 8
“With multiple OMICS datasets, such as the Connectivity Map (cmap) (Lamb, 2007; Lamb et al., 2006), DrugBank (Wishart et al., 2006, 2008), Comparative Toxicogenomics Database (CTD; Davis et al., 2009), the Kyoto Encyclopedia of Genes and Genomes (KEGG; Kanehisa and Goto, 2000; Wixon and Kell, 2000),…”
BackgroundMethodAftab, O., Engskog, M. K. R., Haglöf, J., Elmsjö, A., Arvidsson, T., Pettersson, C. E., Hammerling, U., & Gustafsson, M. G. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500502f · Cited by 9
Wang, L., Ma, S., Hu, Z., McGuire, T. F., & Xie, X.-Q. S. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5757 · Cited by 10
Lin, P., Zhong, X., Wang, X., Li, J., Zhao, R., He, Y., Jiang, Y., Xian-wen, H., Chen, G., He, Y., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6710 · Cited by 10
“Connectivity Map (CMap) is a database containing 7,000 gene expression data profiles treated by ~1,300 compounds (13).”
Zhang, L., Zhou, Y., Zhang, J., Chang, A., & Zhuo, X. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126609 · Cited by 8
Kwak, M. S., Lee, H. H., Cha, J. M., Shin, H. P., Jeon, J. W., & Yoon, J. Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-67801-0 · Cited by 8
Novel genomic methods for drug discovery and mechanism-based toxicological assessment.
Gant, T. W., Zhang, S., & Taylor, E. (2009) · PubMed · Cited by 8
Kameda-Smith, M. M., Zhu, H., Luo, E.-C., Suk, Y., Xella, A., Yee, B., Chokshi, C., Xing, S., Tan, F., Fox, R. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35118-3 · Cited by 7
Gui, J., Yang, L., Liu, J., Li, Y., Zou, M., Sun, C., Huang, L., Zhu, X., & Huang, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24236 · Cited by 8
“The Connectivity Map, a drug discovery database, utilizes pattern-matching algorithms to infer functional associations between drugs, genes, and diseases based on gene expression change information [22].”
BackgroundPolypharmacology and Natural Products
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_15 · Cited by 7
Song, M., Sun, Y., Hu, Y., Wang, C., Jin, Y., Liu, Y., Da, Y., Zhao, Q., Zheng, R., & Li, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112145 · Cited by 7
Kilpinen, S. K., Ojala, K., & Kallioniemi, O. (2011) · BioData Mining · doi:10.1186/1756-0381-4-5 · Cited by 8
“Examples of conceptually similar approaches include the connectivity map [44,45], molecular concept mapping [46], and the relevancy metric [23], which all provide the capability to link new experiments to existing ones.”
BackgroundHuang, J., Wen, F., Huang, W., Bai, Y., Lu, X., & Shu, P. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0608 · Cited by 7
Yeh, S., Yeh, T.-Y., & Chen, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126732 · Cited by 7
“By referring to the connectivity map (CMap) [83], we could find the gene signatures after treating with more than 1300 compounds in numbers of cultivated cell lines.”
MethodZhang, S., Wang, H., & Liu, A. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-4709 · Cited by 7
“We also used a connectivity map (Cmap) to screen out the candidate key gene drugs in DLBCL (13).”
MethodMa, C., Chen, H.-I. H., Flores, M. A., Huang, Y., & Chen, Y. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-s5-s5 · Cited by 9
Ni, M., Ye, F., Zhu, J., Li, Z., Yang, S., Yang, B., Han, L., Wu, Y., Chen, Y., Li, F., et al. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu560 · Cited by 7
“The connectivity map (cMap) project has generated a large number of gene expression profiles of human tumor cell lines treated with over thousands of bioactive small molecules and systematically discovered potential connections among molecules, genes and diseases (Lamb, 2007; Lamb et al ., 2006).”
BackgroundMethod
Metadata
- Authors
- Lamb, J.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Venue
- Nature Reviews Cancer
- Published
- 2007-01
- Volume
- 7
- Issue
- 1
- Pages
- 54-60
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2029980980
- Semantic Scholar
- d1610ee5045d33be16a9a72a514fea537ba46306
- Cited by
- 945
- References
- 66
- Citations by year
- 2026: 11 · 2025: 29 · 2024: 75 · 2023: 54 · 2022: 56 · 2021: 100 · 2020: 79 · 2019: 64 · 2018: 60 · 2017: 52 · 2016: 58 · 2015: 57 · 2014: 42 · 2013: 49 · 2012: 56
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Broad Institute
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene-disease association, drug repurposing, gene expression profiling, cancer research, drug discovery
- MeSH terms
- Algorithms, Animals, Gene Expression Regulation, Humans, Information Services, Models, Biological, Models, Genetic, Neoplasms, Phenotype, Software, Information Storage and Retrieval, Genome, Computational Biology, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.